{"genes":["BRAF","BRAF Val600Glu mutant","cGMP-hydrolysing phosphodiesterase PDE5A","ERK","MAPK","POU-domain transcription factor","BRN2"],"organisms":["6755"],"publicationTypes":["Comment","Journal Article"],"abstract":"In this issue of Cancer Cell, Arozarena etÂ al. describe that the oncogenic BRAF Val600Glu mutant, which occurs in about half of melanomas, downregulates the cGMP-hydrolysing phosphodiesterase PDE5A in melanoma cells through the ERK-MAPK cascade coupled to the POU-domain transcription factor BRN2, thereby increasing intracellular cGMP levels and promoting invasiveness.","title":"Hard times for oncogenic BRAF-expressing melanoma cells.","pubmedId":"21251608"}